EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Accelovance China
President
Asia has had a dramatic spike in interest for medical research pharma advancement and global investment China and India are emerging as leaders in clinical trials They recruit patients faster cheaper and are better than Europe South America or the US because the economies are encouraging more research
Articles
Repurposed Drugs against the Latest Variants of Concerns of SARS-CoV-2
The severe acute respiratory syndrome coronavirus SARSCoV affected all areas of life and the economy by causing COVID and created alarming caution in the form of variants of concerns VoC The latest VoC that are of public health relevance are Alpha B Beta B Gamma P Delta B and Omicron B Due to the emerging spread of these VoCs several vaccines
Research Insights
Bioinformatic Characterization of ENPEP, the Gene Encoding a Potential Cofactor for SARS-CoV-2 Infection
Research on SARSCoV the viral pathogen that causes COVID has identified angiotensin converting enzyme ACE as the primary viral receptor Several genes that encode viral cofactors such as TMPRSS NRP CTSL and possibly KIM have since been discovered Glutamyl aminopeptidase APA encoded by the gene ENPEP is another cofactor candidate due to similarities in its biological
Case Studies
Remarkable Regression Of A Giant Cell Tumor Of The Cervical Spinetreated Conservatively With Denosumab: A Case Study
Abstract This case study has been conducted to establish the fact that Denosumab can be used as an adjuvant therapy by which to avoid or reduce the risks and morbidity of surgical treatment in patients with spinal GCTs extending into the nearby tissues considering the adequate duration safety and lack of adverse events of this treatment even though further
Techno Trends
Japan Plans to Boost Biotechnology Investments through New Public-Private Partnership Initiatives
Japan is launching new initiatives to enhance publicprivate partnerships in the biotechnology sector
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Single Domain Antibody
Senior Researcher and Head of Innovative Product Development, Jotbody (HK) Limited
R&D Lead, Jotbody (HK) Limited
Revolutionising Tuberculosis Treatment test
Adjunct Professor, Tampere University
Researcher, SVKM's Institute of Pharmacy
Tiny Vesicles, Big Impact
Institute of Pharmaceutical Research, GLA University
Lloyd School of Pharmacy
Data-Enriched Edible Pharmaceuticals (DEEP) as Patient-Tailored Drug Products
Associate Professor, University of Copenhagen (UCPH)
Professor, UCPH
Associate Professor, UCPH
Professor, Uppsala University
Perspectives on the Vaccine Industry
Senior Consultant, Process Solutions APAC, Life Science business sector of Merck
press releasesRead more...
Samsung Bioepis and ATLATL Sign Memorandum of Understanding (MoU) to Accelerate Early-Stage Biotech Innovation in Asia-Pacific
Samsung Bioepis Co Ltd and ATLATL Innovation Center hereinafter referred to as ATLATL global innovation platform for life science research and development today announced that the companies have entered
Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of Life-changing Therapies
Thermo Fisher Scientific Inc the world leader in serving science today announced the opening of its flagship US Bioprocess Design Center BDC at the companys Plainville Mass site expanding the facility to support customers
Pfizer Reaches Three Settlement Agreements for VYNDAMAX
Pfizer Inc today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma Hikma Pharmaceuticals and Cipla Ltd regarding lawsuits filed in the US District Court for the District of Delaware for infringement of patents relating to VYNDAMAX tafamidis a trea...
Sun Pharma signs Definitive Agreement to Acquire Organon
Sun Pharmaceutical Industries Limited Reuters SUNBO Bloomberg SUNP IN NSE SUNPHARMA BSE together with its subsidiaries andor associated companies Sun Pharma and Organon Co
Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
Thermo Fisher Scientific Inc NYSE TMO the world leader in serving science today announced that it has signed a definitive agreement to sell its microbiology business to Astorg a leading panEuropean private equity firm
IMG Pharma Enters into Definitive Agreement to Acquire Matsumoto Pharmaceutical
IMG Pharmaceutical Co Ltd IMG Pharma a majorityowned subsidiary of IMG Japan the Groups holding company announced that it has entered into a definitive agreement to acquire Matsumoto Pharmaceutical Co Ltd a Japanese pharmaceutical manufacturer
EventsRead more...
29 - 30
Apr 2026Pharma Partnering US Summit 2026
Hilton San Diego, USA
05 - 06
May 2026GENAP Summit 2026
Vienna, Austria
06 - 07
May 202641th pharmacovigilance USA 2026
Boston, USA
06 - 07
May 20262nd Edition MaxPotent Pharma Summit 2026
Milan, Italy
07 - 08
May 202621st PPM for Pharma & Biotech
New Jersey, USA
10 - 14
May 2026Respiratory Drug Delivery 2026
The Westin Kierland Phoenix, Arizona, USA
12 - 13
May 2026PDA Pharmaceutical Manufacturing 2026
Singapore
14 - 14
May 2026PDA Microbiology in CCS Workshop 2026
Singapore
LATEST NEWSRead more...
Remepy Partners with Merck to Develop Hybrid Drugs Across Therapeutic Areas
Remepy has entered into a collaboration with Merck to advance the development of hybrid drugs across multiple therapeutic areashe initial phase of the partnership will focus on selected programmes in the United States particularly in a rare tumour segment
Gilead Acquires Arcellx to Strengthen Cancer Treatment Pipeline
Gilead Sciences has completed its acquisition of Arcellx in a deal valued at approximately billion Anitocel is a BCMAdirected CAR Tcell therapy that uses a Ddomain binder This design aims to improve CAR expression while reducing unwanted immune activity The therapy is being developed
Taiho Oncology Announces FDA Acceptance of Zipalertinib Application for Advanced Lung Cancer
Taiho Oncology along with Taiho Pharmaceutical and Cullinan Therapeutics has announced that the US Food and Drug Administration FDA has accepted a New Drug Application NDA for zipalertinib
Lilly to Acquire Ajax Therapeutics to Advance Treatments for Myelofibrosis and Polycythaemia Vera
Eli Lilly and Company has entered into a definitive agreement to acquire Ajax Therapeutics Ajaxs lead candidate AJ is an investigational oncedaily oral Type II JAK inhibitor It is currently being evaluated in a Phase clinical trial
Terns Pharmaceuticals Receives Breakthrough Therapy for TERN-701 in Chronic Myeloid Leukemia (CML)
Terns Pharmaceuticals has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation BTD to TERN an investigational oral allosteric BCRABL inhibitor
Cipla Secures US FDA Approval for First AB-Rated Generic of Ventolin HFA
Cipla and its subsidiary Cipla USA have received final approval from the US Food and Drug Administration FDA for their Abbreviated New Drug Application ANDA for Albuterol Sulfate Inhalation Aerosol mcg per actuation The product is the first ABrated generic equivalent of Ventolin HFA originally mark...
